Loading provider…
Loading provider…
Hematology & Oncology Physician in Bozeman, MT
NPI: 1316998362Primary Practice Location
BOZEMAN HEALTH DEACONESS HOSPITAL
915 Highland Blvd, Bozeman, MT
Primary Employer
Bozeman Health Deaconess Hospital
bozemanhealth.org
HQ Phone
Get MD William's Phone Numberphone_androidMobile
Get MD William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
WI State Medical License
KY State Medical License
MT State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 102 | 162 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 64 | 85 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 57 | 57 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 51 | 59 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 20 | 20 |
Authors: Ari Baron, Frederick Millard
Journal: Cancer Chemother Pharmacol
Publication Date: 2014-04-10
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, DRUG: Gemcitabine Hydrochloride, DRUG: Paclitaxel, PROCEDURE: Computed Tomography, DRUG: Pemetrexed Disodium, PROCEDURE: Echocardiography Test, OTHER: Observation Activity
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Paclitaxel, DRUG: Etoposide, BIOLOGICAL: Durvalumab, DRUG: Pemetrexed Disodium
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, PROCEDURE: Computed Tomography, RADIATION: Stereotactic Body Radiation Therapy